[1] Grattepanche, Astrid Cécile Emma. « Probiotiques gynécologiques en officine », s. d.
[2] Mändar, R., G. Sõerunurk, J. Štšepetova, I. Smidt, T. Rööp, S. Kõljalg, M. Saare, et al. « Impact of Lactobacillus Crispatus-Containing Oral and Vaginal Probiotics on Vaginal Health: A Randomised Double-Blind Placebo Controlled Clinical Trial », 14 avril 2023. https://doi.org/10.3920/BM2022.0091.
[3] Gudnadottir, Unnur, Justine W. Debelius, Juan Du, Luisa W. Hugerth, Hanna Danielsson, Ina Schuppe-Koistinen, Emma Fransson, et Nele Brusselaers. « The Vaginal Microbiome and the Risk of Preterm Birth: A Systematic Review and Network Meta-Analysis ». Scientific Reports 12, no 1 (13 mai 2022): 7926. https://doi.org/10.1038/s41598-022-12007-9.
[4] Slykerman, R. F., F. Hood, K. Wickens, J. M. D. Thompson, C. Barthow, R. Murphy, J. Kang, et al. « Effect of Lactobacillus Rhamnosus HN001 in Pregnancy on Postpartum Symptoms of Depression and Anxiety: A Randomised Double-Blind Placebo-Controlled Trial ». EBioMedicine 24 (octobre 2017): 159‑65. https://doi.org/10.1016/j.ebiom.2017.09.013.
[5] Ho, Ming, Yin-Yi Chang, Wei-Chun Chang, Hung-Chih Lin, Mei-Hung Wang, Wu-Chou Lin, et Tsan-Hung Chiu. « Oral Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 to reduce Group B Streptococcus colonization in pregnant women: A randomized controlled trial ». Taiwanese Journal of Obstetrics and Gynecology 55, no 4 (1 août 2016): 515‑18. https://doi.org/10.1016/j.tjog.2016.06.003.
[6] Sabaté, Jean-Marc, et Franck Iglicki. « Effect of Bifidobacterium Longum 35624 on Disease Severity and Quality of Life in Patients with Irritable Bowel Syndrome ». World Journal of Gastroenterology 28, no 7 (21 février 2022): 732. https://doi.org/10.3748/wjg.v28.i7.732.
[7] Solovyeva et al. « Long-term probiotic administration for irritable bowel syndrome: a legal need ». Terapevticheskii arkhiv 95, no 8 (11 octobre 2023): 679‑85. https://doi.org/10.26442/00403660.2023.08.202378.